glutamine has been researched along with Liver Neoplasms in 123 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 36 (29.27) | 18.7374 |
| 1990's | 13 (10.57) | 18.2507 |
| 2000's | 11 (8.94) | 29.6817 |
| 2010's | 23 (18.70) | 24.3611 |
| 2020's | 40 (32.52) | 2.80 |
| Authors | Studies |
|---|---|
| Cordes, T; Kumar, A; Metallo, CM; Murphy, AN; Pajor, AM; Thalacker-Mercer, AE | 1 |
| Jhu, JW; Lin, SC; Lin, ZH; Peng, IC; Yan, JB | 1 |
| Chen, X; Cheng, M; Hu, Z; Li, X; Lu, Y; Shen, B; Tao, Q; Wang, D; Xiong, F; Ying, L | 1 |
| Chen, J; Chen, L; Chen, P; Cui, HS; Fu, GB; Huang, S; Liu, J; Luo, FF; Wang, HY; Xu, W; Yan, HX; Yu, JH; Zeng, J; Zhai, B; Zhang, HL; Zhang, J; Zhao, SM | 1 |
| Fan, D; Fu, R; Lu, H; Ma, X; Qu, L; Yin, H | 1 |
| Chen, HL; Huang, Y; Lu, SF; Lu, Y; Wu, L; Xing, ML; Yang, FR; Yang, QW; Zhang, YT | 1 |
| Cheng, C; Jiang, X; Li, B; Li, H; Li, Y; Liu, Q; Meng, G; Qian, L; Sun, B; Wang, Y; Xie, Y; Xu, T; Xu, Y; Yu, D; Zhang, L | 1 |
| Hosokawa, H; Kanda, H; Lee, E; Miki, T; Nakayama, A; Prives, C; Stockwell, BR; Suzuki, S; Tanaka, T; Venkatesh, D; Yokote, K | 1 |
| Cheng, B; Huang, L; Li, L; Xing, T | 1 |
| Chen, X; Craig, MC; Feng, J; Murphy, ST; Seo, Y; Yuneva, M | 1 |
| Chakraborti, A; Dhiman, RK; Kanthaje, S; Kaur, R; Taneja, S | 1 |
| Abd Elbaset, M; Ahmed, RF; Ahmed-Farid, OAH; Hessin, AF; Nasr, M; Shabana, ME; Shaffie, NM | 1 |
| Feng, J; Fu, Q; Guo, J; Ling, B; Ning, K; Wang, J; Wu, B; Xiu, G; Xu, J | 1 |
| Balakrishnan, K | 1 |
| Bott, AJ; Chen, X; Daguplo, HQ; Dai, W; Ding, WX; Gao, S; Guo, JY; Khayati, K; Maimouni, S; Shen, J; Su, X; Valvezan, A; Wang, Y; Yan, J; Zhang, L; Zong, WX | 1 |
| Adamski, J; Ardanaz, E; Barranco, MR; Bonet, C; Breeur, M; Bueno-de-Mesquita, B; Chirlaque, MD; Dossus, L; Eichelmann, F; Ferrari, P; Grioni, S; Gunter, MJ; Heath, AK; His, M; Jenab, M; Johansson, M; Kaaks, R; Katzke, V; Keski-Rahkonen, P; Keun, H; Key, TJ; Kyrø, C; Laouali, N; Manjer, J; Muller, D; Nøst, TH; Olsen, KS; Overvad, K; Palli, D; Panico, S; Quirós, JR; Rentoft, M; Rinaldi, S; Rothwell, JA; Sacerdote, C; Sandanger, TM; Sandsveden, M; Scalbert, A; Schmidt, JA; Schulze, MB; Severi, G; Tjønneland, A; Travis, RC; Tsilidis, K; Tumino, R; Viallon, V; Vidman, L | 1 |
| Huo, X; Liu, T; Wang, H; Wang, J; Xue, L; Yuan, Z | 1 |
| Bai, J; Chang, J; Shi, J; Sun, C; Tang, R; Wang, H; Zhang, Q; Zhou, K | 1 |
| Bao, MH; Chan, CY; Chen, Y; Lee, D; Tse, AP; Wei, L; Wong, BP; Wong, CC; Yang, C; Yuen, VW; Zhang, MS | 1 |
| Cai, Y; Feng, J; Gao, P; Jia, W; Li, ST; Liu, H; Lu, K; Song, W; Wang, T; Xing, S; Yang, D; Ye, L; Zhang, H; Zhang, P; Zhang, Y; Zhong, X; Zhu, X | 1 |
| Chen, J; Fan, J; Li, B; Li, X; Liu, S; Liu, Z; Tan, S; Wang, R; Yang, X | 1 |
| Ding, J; Li, D; Lin, B; Luo, J; Shang, M; Wang, W; Xu, K; Zheng, S; Zhou, L | 1 |
| Chakraborty, S; Chen, D; Lorenzi, PL; Mou, H; Qian, X; Tan, L; Wei, B; Wei, D; Yang, P | 1 |
| Chen, X; Deng, Q; Ding, ZY; Hua, A; Li, S; Li, Z; Wan, J; Wang, C; Wang, Q; Xiong, Y; Xu, C; Yang, T; Yang, X; Zhang, BX | 1 |
| Gao, L; Kong, Y; Li, C; Liang, X; Ma, C; Sun, M; Wan, X; Wu, M; Wu, Z; Yue, X; Zhang, Y | 1 |
| Liu, Y; Miao, Z; Wang, Y; Yang, Q; Zhao, Y | 1 |
| Feng, HG; Gong, JP; Miao, CM; Wu, CX; Xiong, B; Zhong, GC | 1 |
| Cai, W; Chen, Z; Ding, Y; Jiang, H; Song, X; Wu, X; Xu, J; Xu, Q; Ying, H; Ying, K; Yu, F; Zeng, L; Zeng, Y; Zhang, X; Zhao, L; Zhou, R | 1 |
| Das, PK; Ghosh, A; Ghosh, AK; Zaman, A | 1 |
| Fang, D; Hu, Y; Jiang, J; Luo, J | 1 |
| Buchanan, JL; Dupuy, AJ; Gray, LR; Mapuskar, KA; Noterman, MF; Oonthonpan, L; Pewa, AD; Rauckhorst, AJ; Scerbo, DA; Sharma, A; Sheldon, RD; Solst, SR; Spitz, DR; Taylor, EB; Tompkins, SC | 1 |
| Dai, W; Dong, L; Guo, C; Guo, H; Liu, H; Liu, T; Shen, X; Song, G; Weng, S; Xu, L; Yu, X; Zhang, G; Zhu, J | 1 |
| Bakker, BM; Engqvist, M; Gerding, A; Haanstra, JR; Klingmüller, U; Nielsen, J; Nilsson, A; Teusink, B | 1 |
| Charles, M; Chen, X; Driscoll, PC; Hay, N; Jones, NP; Legrave, N; Li, V; Lin, W; MacRae, JI; Méndez-Lucas, A; Novellasdemunt, L; Rayport, S; Rodríguez-Justo, M; Wilson, Z; Xie, C; Yuneva, M | 1 |
| Guan, R; Huang, J; Jian, Z; Jin, H; Lin, Y; Wei, X; Wu, X; Zou, X | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Sunami, Y | 1 |
| Beijersbergen, R; Berkers, CR; Bernards, R; Bosma, A; Isima, N; Jin, G; Jin, H; Jochems, F; Lieftink, C; Qin, W; Wang, C; Wang, S; Wu, H; Zaal, EA | 1 |
| Kong, SK; Kwan, YW; Lau, PM; Lee, ACK | 1 |
| Armento, A; Bussolati, O; Chiu, M; Ellerkamp, V; Fuchs, J; Sander, P; Scharpf, MO; Schmid, E; Schmidt, A; Warmann, SW | 1 |
| Cai, Z; Che, N; Lee, TK; Li, CH; Ma, S; Man, K; Tong, M; Wong, TL; Xie, YN; Yun, JP; Zhao, H; Zheng, Y; Zhou, L | 1 |
| Choi, YK; Ham, HJ; Jang, SY; Jeon, HJ; Kim, BG; Kim, JG; Kim, JH; Kim, MJ; Lee, IK; Lee, JY; Park, KG; Park, SY | 1 |
| Giri, S; Kumar, A; Shaha, C | 1 |
| Gao, Y; Li, Y; Liu, Z; Peng, Q | 1 |
| Adebayo Michael, AO; Calvisi, D; Chen, X; Görg, B; Häussinger, D; Ko, S; Liu, P; Liu, S; Moghe, A; Monga, JS; Monga, SP; Oertel, M; Poddar, M; Pradhan-Sundd, T; Qvartskhava, N; Ranganathan, S; Rebouissou, S; Ribback, S; Russell, JO; Singh, S; Singhi, A; Tao, J; Xu, M; Yang, H; Zucman-Rossi, J | 1 |
| Chen, M; Cheng, X; Fan, X; Gao, H; Ji, J; Lu, S; Song, J; Weng, Q; Xu, M; Yang, W; Zheng, H; Zheng, L | 1 |
| Goessling, W | 1 |
| Decaens, T; Perret, C | 1 |
| Green, MF; Hirschey, MD; McDonnell, E; Wang, D | 1 |
| Arcangeli, A; Armeanu-Ebinger, S; Armento, A; Barilli, A; Bianchi, MG; Bussolati, O; Campanini, N; Chiu, M; Dall'Asta, V; Fuchs, J; Missale, G; Pillozzi, S; Silini, EM; Tardito, S; Uggeri, J | 1 |
| Albert, V; Cornu, M; Fuhrer, T; Hall, MN; Oppliger, W; Quagliata, L; Robitaille, AM; Sauer, U; Terracciano, L; Trapani, F | 1 |
| Byun, JK; Choi, YK; Harris, RA; Jang, BK; Jeon, JH; Jeon, YH; Jeong, WI; Kang, KJ; Kang, YN; Koo, SH; Lee, HW; Lee, IK; Park, KG | 1 |
| Akagi, Y; Matono, K; Ogata, Y; Shirouzu, K; Tsuda, H; Uchida, S; Ushijima, M | 1 |
| Aguilar-Mahecha, A; Amir, E; Andrzejewski, S; Annis, MG; Basik, M; Blagih, J; Clemons, M; Dong, Z; Dupuy, F; Gao, D; Jones, RG; Leung, S; Omeroglu, A; Siegel, PM; St-Pierre, J; Tabariès, S; Vincent, EE | 1 |
| Auwerx, J; Can, E; Comment, A; Demagny, H; Moullan, N; Oosterveer, MH; Ryu, D; Schoonjans, K; Stein, S; Wang, X; Xu, P; Zamboni, N | 1 |
| Asara, JM; Beltz, S; Brown, KK; Camargo, FD; Chhangawala, S; Cohen, DE; Cox, AG; Evason, K; Galli, GG; Goessling, W; Houvras, Y; Hwang, KL; Lien, EC; Minami, A; Nissim, S; O'Connor, K; Stainier, DYR; Tsomides, A; Wucherpfennig, J; Yimlamai, D; Yuan, M | 1 |
| Bartosch, B; Dienes, HP; Diserens, G; Dufour, JF; Duponchel, S; Eischeid, H; Lévy, PL; Michelet, M; Molle, J; Odenthal, M; Steffen, HM; Vermathen, M; Vermathen, P; Zoulim, F | 1 |
| Anderton, B; Balakrishnan, A; Balakrishnan, S; Camarda, R; Evason, KJ; Goga, A; Huang, Q; Kohnz, RA; Kruttwig, K; Lim, L; Momcilovic, O; Nomura, DK; Xu, G | 1 |
| Chen, HB; Gao, J; Li, L; Li, XQ; Yan, XZ; Zhang, Q | 1 |
| Brindle, KM; Day, SE; Gallagher, FA; Kettunen, MI; Lerche, M | 1 |
| Bian, DJ; Chen, XY; Hu, DX; Situ, WJ; Sun, JL; Xiao, EH; Yang, LP; Yuan, SW | 1 |
| ERRERA, M; GREENSTEIN, JP | 1 |
| Hirayama, A; Honma, M; Igarashi, K; Ikeda, S; Kashikura, K; Kawata, S; Mori, M; Nihei, K; Otsuka, M; Saito, T; Sakuragawa, T; Soga, T; Suematsu, M; Sugimoto, M; Suzuki, H; Tomita, M; Tsuji, S; Watanabe, H; Yamamoto, T; Yatomi, Y; Yoshida, H | 1 |
| Bussolati, O; Chiu, M; Da Ros, F; Dall'Asta, V; Missale, G; Tardito, S; Uggeri, J; Zerbini, A | 1 |
| Bois, FY; Cheng, S; Leclerc, E; Prot, JM | 1 |
| Aeberhard, L; Eilers, M; Kempa, S; Kress, TR; Liu, L; Moll, R; Müller, J; Murphy, DJ; Muthalagu, N; Rudalska, R; Rycak, L; Ulbrich, J; Wüstefeld, T; Zender, L | 1 |
| Abcouwer, SF; Bode, BP; Conroy, JL; Fuchs, BC; Hurley, BP; Rhoads, DB; Souba, WW; Suetterlin, JE; Tanabe, KK | 1 |
| Ammatuna, M; Battezzati, A; Caumo, A; Coppa, J; Luzi, L; Martino, F; Matthews, DE; Mazzaferro, V; Regalia, E; Romito, R; Sereni, LP | 1 |
| BURKE, WT; MILLER, LL | 1 |
| LORINCZ, AB; RYAN, WL | 1 |
| BAUER, JM; ROBERTS, EH; WU, C | 1 |
| Bode, BP; Chaudhry, SB; Fuchs, BC; Perez, JC; Suetterlin, JE | 1 |
| Bungard, CI; McGivan, JD | 2 |
| Wang, Y; Watford, M | 1 |
| Blanke, CD; Chan, JS; Harding, CO | 1 |
| Hattori, N; Nakagen, M; Ozaki, K; Sawabu, N; Toya, D; Wakabayashi, T | 1 |
| Christensen, HN; Vadgama, JV | 1 |
| Feuer, L; Gergely, P; Kalmár, L; Láng, I; Nèkám, K; Török, K | 1 |
| Gebhardt, R; Williams, GM | 1 |
| Abramson, FP; Kusmierz, JJ | 1 |
| Kato, Y; Kouno, M; Miyashita, M; Mizuno, H; Okabe, K; Sato, A; Suzuki, H; Suzuki, M; Tominaga, T | 1 |
| Bode, BP; Souba, WW | 1 |
| Bode, BP; Souba, WW; Wasa, M | 1 |
| Kishimoto, T; Kokura, K; Kumagai, Y; Makino, Y; Tamura, T; Wakamatsu, T | 1 |
| Hara, H; Iemura, A; Sata, M; Tsuda, H; Uchida, M; Yamana, K | 1 |
| Czaja, MJ; Lo, DC; Nguyen, Q; Xu, Y | 1 |
| McGivan, JD | 1 |
| Banine, F; Claeyssens, S; Lavoinne, A; Rouet, P; Salier, JP | 1 |
| Bode, BP; Pawlik, TM; Souba, WW; Sweeney, TJ | 1 |
| Liu, SL; Shen, ZH; Shi, DY; Wu, YD | 1 |
| Freikopf, A; Kulka, RG | 2 |
| Bagaglio, JF; Mokotoff, M; Parikh, BS | 1 |
| Bagaglio, JF; Brynes, S; Mokotoff, M | 1 |
| Goto, I; Matsuno, T | 1 |
| Easton, AJ; McLachlan, A; Milich, DR; Raney, AK | 1 |
| Matsuno, T | 1 |
| Hussain, MM; Plaitakis, A; Zannis, VI | 1 |
| Bading, JR; Benua, RS; Daly, JM; Gelbard, AS; Ridge, JA | 1 |
| Cohen, H; Kulka, RG | 1 |
| Cohen, L; Eagle, H; Levy, M; Washington, CL | 1 |
| Bresnick, E; Lyman, K; Mayfield, ED | 1 |
| Orr, GR; Patterson, MK | 1 |
| Horowitz, ML; Knox, WE | 1 |
| Raina, PN; Rosen, F | 1 |
| Knox, WE; Kupchik, HZ | 1 |
| Morris, HP; Wu, C | 1 |
| Knox, WE; Kupchik, HZ; Liu, LP | 1 |
| Kikuchi, H; Kobayashi, Y; Tsuiki, S | 1 |
| Kikuchi, H; Kikuchi, K; Tsuiki, S | 1 |
| Chou, TC; Handschumacher, RE | 1 |
| Martin, DW | 1 |
| Kattermann, R; Schenzer, R; Schlaeger, R | 1 |
| Greengard, O; Richards, TC | 1 |
| Hogan, BL; Murden, S | 1 |
| Hoogenraad, NJ; Lee, DC | 1 |
| Miyagi, T; Tsuiki, S | 1 |
| Katunuma, N; Weber, G | 1 |
| Kovacević, Z; Morris, HP | 1 |
| Crook, RB; Kulka, RG; Tokins, GM | 1 |
| Oppenheimer, SB | 1 |
| Hupli, V; Konttinen, A; Salmenkivi, K | 1 |
4 review(s) available for glutamine and Liver Neoplasms
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
NASH, Fibrosis and Hepatocellular Carcinoma: Lipid Synthesis and Glutamine/Acetate Signaling.
Topics: Acetates; Acetyl Coenzyme A; Acyltransferases; Carcinoma, Hepatocellular; Clinical Trials as Topic; Fatty Acid Desaturases; Fatty Acids; Fibrosis; Glutamine; Humans; Lipid Metabolism; Lipids; Liver Neoplasms; Metabolic Networks and Pathways; Non-alcoholic Fatty Liver Disease; Signal Transduction; Sterol Regulatory Element Binding Proteins | 2020 |
The transport of glutamine into mammalian cells.
Topics: Amino Acid Transport System ASC; Biological Transport; Brain; Carcinoma, Hepatocellular; Carrier Proteins; Glutamine; Humans; Kidney; Liver; Liver Neoplasms; Minor Histocompatibility Antigens; Transcriptional Activation | 2007 |
Glutamine synthetase and hepatocarcinogenesis.
Topics: Animals; Glutamate-Ammonia Ligase; Glutamine; Humans; Liver; Liver Neoplasms; Precancerous Conditions | 1995 |
4 trial(s) available for glutamine and Liver Neoplasms
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Randomized phase II study of 5-fluorouracil hepatic arterial infusion with or without antineoplastons as an adjuvant therapy after hepatectomy for liver metastases from colorectal cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Benzeneacetamides; Chemotherapy, Adjuvant; Colorectal Neoplasms; Drug Combinations; Fluorouracil; Glutamine; Hepatectomy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Phenylacetates; Piperidones; Survival Analysis; Treatment Outcome | 2015 |
Serum metabolomics reveals γ-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease.
Topics: Aged; Biomarkers; Carcinoma, Hepatocellular; Diagnosis, Differential; Dipeptides; Fatty Liver; Female; Glutamine; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Male; Metabolomics; Middle Aged; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Protein Array Analysis; Reproducibility of Results | 2011 |
Nonhepatic glucose production in humans.
Topics: Adult; Alanine; Blood Glucose; Carcinoma; Follow-Up Studies; Gluconeogenesis; Glutamine; Hepatectomy; Humans; Kidney; Liver; Liver Neoplasms; Liver Transplantation; Middle Aged | 2004 |
116 other study(ies) available for glutamine and Liver Neoplasms
| Article | Year |
|---|---|
NaCT/SLC13A5 facilitates citrate import and metabolism under nutrient-limited conditions.
Topics: Acetyl Coenzyme A; Adult; Animals; Carcinoma, Hepatocellular; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Citrates; Female; Gene Editing; Glutamine; Humans; Lipogenesis; Liver Neoplasms; Male; Neurons; Nutrients; Rats; Symporters; Zinc | 2021 |
SREBP1-Induced Glutamine Synthetase Triggers a Feedforward Loop to Upregulate SREBP1 through Sp1 O-GlcNAcylation and Augments Lipid Droplet Formation in Cancer Cells.
Topics: Acetyl-CoA Carboxylase; beta-N-Acetylhexosaminidases; Breast Neoplasms; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glutamate-Ammonia Ligase; Glutamine; Humans; Insulin; Lipids; Liver Neoplasms; Metabolism; Promoter Regions, Genetic; Protein Biosynthesis; Signal Transduction; Sp1 Transcription Factor; Sterol Regulatory Element Binding Protein 1 | 2021 |
Glutamine Metabolism Scoring Predicts Prognosis and Therapeutic Resistance in Hepatocellular Carcinoma.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cohort Studies; Drug Resistance, Neoplasm; Female; Glutamine; Humans; Liver Neoplasms; Male; Middle Aged; Prognosis; Transcriptome | 2021 |
Targeting mTORC2/HDAC3 Inhibits Stemness of Liver Cancer Cells Against Glutamine Starvation.
Topics: Cell Line; Glutamate-Ammonia Ligase; Glutamine; Histone Deacetylases; Humans; Liver Neoplasms; Mechanistic Target of Rapamycin Complex 2; Transcription Factors | 2022 |
Ginsenoside Rk1 regulates glutamine metabolism in hepatocellular carcinoma through inhibition of the ERK/c-Myc pathway.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Ginsenosides; Glutamine; Humans; Liver Neoplasms; Proto-Oncogene Proteins c-myc; Signal Transduction | 2022 |
Multi-material basis and multi-mechanisms of the Dahuang Zhechong pill for regulating Treg/Th1 balance in hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Drugs, Chinese Herbal; Emodin; Glutamine; Liver Neoplasms; Mice; T-Lymphocytes, Regulatory; Tandem Mass Spectrometry; Transforming Growth Factor beta; Tumor Microenvironment | 2022 |
GOT2 Silencing Promotes Reprogramming of Glutamine Metabolism and Sensitizes Hepatocellular Carcinoma to Glutaminase Inhibitors.
Topics: Animals; Antioxidants; Aspartate Aminotransferase, Mitochondrial; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glutaminase; Glutamine; Glutathione; Humans; Liver Neoplasms; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases | 2022 |
GLS2 Is a Tumor Suppressor and a Regulator of Ferroptosis in Hepatocellular Carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Ferroptosis; Glutamates; Glutaminase; Glutamine; Humans; Iron; Ketoglutaric Acids; Lipid Peroxides; Liver Neoplasms; Mice; Reactive Oxygen Species | 2022 |
SLC38A6, regulated by EP300-mediated modifications of H3K27ac, promotes cell proliferation, glutamine metabolism and mitochondrial respiration in hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; E1A-Associated p300 Protein; Gene Expression Regulation, Neoplastic; Glutamine; Humans; Liver Neoplasms; Respiration | 2022 |
[
Topics: Animals; Carcinoma, Hepatocellular; Disease Models, Animal; Glutamine; Liver Neoplasms; Mice; Mice, Transgenic; Positron-Emission Tomography | 2022 |
miR-23b-3p Modulating Cytoprotective Autophagy and Glutamine Addiction in Sorafenib Resistant HepG2, a Hepatocellular Carcinoma Cell Line.
Topics: Autophagy; Carcinoma, Hepatocellular; Cell Line; Chloroquine; Gene Expression Regulation, Neoplastic; Glutamine; Humans; Liver Neoplasms; MicroRNAs; Sorafenib | 2022 |
Combating hematopoietic and hepatocellular abnormalities resulting from administration of cisplatin: role of liver targeted glycyrrhetinic acid nanoliposomes loaded with amino acids.
Topics: Amino Acids; Arginine; Carcinoma, Hepatocellular; Cisplatin; Glutamine; Glycyrrhetinic Acid; Humans; Liver Neoplasms | 2022 |
ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis.
Topics: Ammonia; Animals; Carbon Tetrachloride; Carcinoma, Hepatocellular; Diethylnitrosamine; Exosomes; Fibrosis; Glutamate-Ammonia Ligase; Glutamine; Hepatic Stellate Cells; Homeostasis; Liver Cirrhosis; Liver Neoplasms; Mice; Stromal Cells; Transforming Growth Factor beta | 2022 |
Hepatocellular carcinoma stage: an almost loss of fatty acid metabolism and gain of glucose metabolic pathways dysregulation.
Topics: Acetyl-CoA Carboxylase; Acyl-CoA Dehydrogenases; Carcinogenesis; Carcinoma, Hepatocellular; Fatty Acids; Glucose; Glutamine; Humans; Liver Neoplasms; Metabolic Networks and Pathways; Oxidoreductases; Phosphoglycerate Kinase; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Pyruvates | 2022 |
Glutamine synthetase limits β-catenin-mutated liver cancer growth by maintaining nitrogen homeostasis and suppressing mTORC1.
Topics: Ammonia; Animals; beta Catenin; Glutamate-Ammonia Ligase; Glutamine; Homeostasis; Liver; Liver Neoplasms; Mechanistic Target of Rapamycin Complex 1; Mice; Nitrogen; Urea | 2022 |
Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition.
Topics: Carcinoma, Hepatocellular; Case-Control Studies; Glutamine; Histidine; Humans; Liver Neoplasms; Lysophosphatidylcholines; Male; Phosphatidylcholines; Proline; Prospective Studies; Risk Factors; Sphingomyelins | 2022 |
Glutamine Transporter SLC1A5 Regulates Ionizing Radiation-Derived Oxidative Damage and Ferroptosis.
Topics: Amino Acid Transport System ASC; Ferroptosis; Glutamine; Humans; Liver Neoplasms; Minor Histocompatibility Antigens; Oxidative Stress; Radiation, Ionizing | 2022 |
An asparagine metabolism-based classification reveals the metabolic and immune heterogeneity of hepatocellular carcinoma.
Topics: Asparagine; Aspartate Aminotransferases; Biomarkers, Tumor; Carcinoma, Hepatocellular; Gene Expression Profiling; Glutamine; Humans; Liver Neoplasms; Prognosis; Tumor Microenvironment | 2022 |
Genome-Wide CRISPR/Cas9 Library Screening Revealed Dietary Restriction of Glutamine in Combination with Inhibition of Pyruvate Metabolism as Effective Liver Cancer Treatment.
Topics: Animals; Carcinoma, Hepatocellular; CRISPR-Cas Systems; Early Detection of Cancer; Glutamine; Liver Neoplasms; Mice; Mice, Knockout; Oxidoreductases; Pyruvic Acid | 2022 |
Branched-chain amino acid catabolism breaks glutamine addiction to sustain hepatocellular carcinoma progression.
Topics: Amino Acids, Branched-Chain; Carcinogenesis; Carcinoma, Hepatocellular; Glutamine; Humans; Liver Neoplasms | 2022 |
Unbalanced Glutamine Partitioning between CD8T Cells and Cancer Cells Accompanied by Immune Cell Dysfunction in Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; CD8-Positive T-Lymphocytes; Glutamine; Humans; Liver Neoplasms; Tumor Microenvironment | 2022 |
SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism via c-Myc/GLS1 Axis.
Topics: Carcinoma, Hepatocellular; Glutamine; Histone-Lysine N-Methyltransferase; Humans; Liver Neoplasms; Sorafenib | 2022 |
Targeting Glutamine Metabolism with a Novel Na+/K+-ATPase Inhibitor RX108 in Hepatocellular Carcinoma.
Topics: Adenosine Triphosphatases; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Glutamine; Humans; Liver Neoplasms; Mice | 2023 |
A novel lonidamine derivative targeting mitochondria to eliminate cancer stem cells by blocking glutamine metabolism.
Topics: Antineoplastic Agents; Cell Line, Tumor; Glutamine; Humans; Liver Neoplasms; Mitochondria; Neoplastic Stem Cells | 2023 |
Lipophagy-mediated cholesterol synthesis inhibition is required for the survival of hepatocellular carcinoma under glutamine deprivation.
Topics: Autophagy; Carcinoma, Hepatocellular; Cell Line, Tumor; Cholesterol; Glutamine; Humans; Liver Neoplasms; Tumor Microenvironment | 2023 |
c-Myc protects hepatocellular carcinoma cell from ferroptosis induced by glutamine deprivation via upregulating GOT1 and Nrf2.
Topics: Aspartate Aminotransferase, Cytoplasmic; Carcinoma, Hepatocellular; Cell Line, Tumor; Ferroptosis; Glutamine; Humans; Liver Neoplasms; NF-E2-Related Factor 2 | 2023 |
Integrative analysis reveals that SLC38A1 promotes hepatocellular carcinoma development via PI3K/AKT/mTOR signaling via glutamine mediated energy metabolism.
Topics: Amino Acid Transport System A; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Energy Metabolism; Glutamine; Humans; Liver Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases | 2023 |
Canagliflozin reduces chemoresistance in hepatocellular carcinoma through PKM2-c-Myc complex-mediated glutamine starvation.
Topics: Canagliflozin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Glutamine; Glycolysis; Humans; Liver Neoplasms; Proto-Oncogene Proteins c-myc; Thyroid Hormone-Binding Proteins | 2023 |
Metformin-Loaded Hyaluronic Acid-Derived Carbon Dots for Targeted Therapy against Hepatocellular Carcinoma by Glutamine Metabolic Reprogramming.
Topics: Carbon; Carcinoma, Hepatocellular; Cell Line, Tumor; Glutamine; HEK293 Cells; Humans; Hyaluronan Receptors; Hyaluronic Acid; Liver Neoplasms; Metformin; Reactive Oxygen Species; Tumor Microenvironment | 2023 |
Glutamine synthetase and hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Glutamate-Ammonia Ligase; Glutamine; Glypicans; Humans; Liver Neoplasms; Wnt Signaling Pathway | 2023 |
Disrupting Mitochondrial Pyruvate Uptake Directs Glutamine into the TCA Cycle away from Glutathione Synthesis and Impairs Hepatocellular Tumorigenesis.
Topics: Animals; Apoptosis; Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Citric Acid Cycle; Glutamine; Glutathione; Hepatocytes; Humans; Liver Neoplasms; Mice, Inbred C57BL; Mitochondria; Neoplasm Proteins; Organ Specificity; Pyruvic Acid; Transcriptome | 2019 |
OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cohort Studies; Drug Resistance, Neoplasm; Female; Gene Silencing; Glutamine; Humans; Ketoglutarate Dehydrogenase Complex; Lipid Metabolism; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Signal Transduction; Sorafenib; Tumor Burden; Xenograft Model Antitumor Assays | 2020 |
Quantitative analysis of amino acid metabolism in liver cancer links glutamate excretion to nucleotide synthesis.
Topics: Adenosine Triphosphate; Carcinoma, Hepatocellular; Cells, Cultured; Citric Acid Cycle; Cytosol; Energy Metabolism; Glutamic Acid; Glutamine; Hep G2 Cells; Humans; Liver Neoplasms; Mitochondria | 2020 |
Identifying strategies to target the metabolic flexibility of tumours.
Topics: Animals; Cell Proliferation; Glucose; Glutaminase; Glutamine; Humans; Liver Neoplasms; Mice; Proto-Oncogene Proteins c-myc | 2020 |
The cross-talk between DDR1 and STAT3 promotes the development of hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Discoidin Domain Receptor 1; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Gene Silencing; Glutamine; Humans; Liver Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Phosphorylation; Prognosis; Receptor Cross-Talk; STAT3 Transcription Factor | 2020 |
A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer.
Topics: Amino Acid Transport System ASC; Animals; Antineoplastic Agents; Apoptosis; Benzeneacetamides; Carrier Proteins; Cell Line, Tumor; Drug Synergism; Glutaminase; Glutamine; Humans; Liver Neoplasms; Mice; Minor Histocompatibility Antigens; Reactive Oxygen Species; Thiadiazoles; Xenograft Model Antitumor Assays | 2020 |
Mitochondrial Fuel Dependence on Glutamine Drives Chemo-Resistance in the Cancer Stem Cells of Hepatocellular Carcinoma.
Topics: Adenosine Triphosphate; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; Glucose; Glutamine; Hep G2 Cells; Humans; Liver Neoplasms; Mitochondria; Neoplastic Stem Cells; Oxidative Phosphorylation; Phenotype | 2021 |
Hepatoblastoma: glutamine depletion hinders cell viability in the embryonal subtype but high GLUL expression is associated with better overall survival.
Topics: beta Catenin; Carbon-Nitrogen Ligases with Glutamine as Amide-N-Donor; Cell Line, Tumor; Cell Survival; Exons; Gene Expression; Glutamate-Ammonia Ligase; Glutamine; Hepatoblastoma; Humans; Liver Neoplasms; Mutation | 2021 |
Loss of tyrosine catabolic enzyme HPD promotes glutamine anaplerosis through mTOR signaling in liver cancer.
Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Animals; Cell Line, Tumor; Glutamine; Humans; Liver; Liver Neoplasms; Mice, Inbred BALB C; TOR Serine-Threonine Kinases; Tyrosine | 2021 |
PPARδ Reprograms Glutamine Metabolism in Sorafenib-Resistant HCC.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance, Neoplasm; Glutamine; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Niacinamide; Phenylurea Compounds; PPAR delta; Random Allocation; Sorafenib; Transfection; Xenograft Model Antitumor Assays | 2017 |
Sestrin2 facilitates glutamine-dependent transcription of PGC-1α and survival of liver cancer cells under glucose limitation.
Topics: Blotting, Western; Cell Proliferation; Cell Survival; Glucose; Glutamine; Hep G2 Cells; Humans; Liver Neoplasms; Nuclear Proteins; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Real-Time Polymerase Chain Reaction; Transcription, Genetic | 2018 |
Resveratrol enhances cisplatin-induced apoptosis in human hepatoma cells via glutamine metabolism inhibition.
Topics: Amino Acid Transport System ASC; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Cisplatin; Down-Regulation; Drug Screening Assays, Antitumor; Flow Cytometry; Glutamine; Humans; Liver Neoplasms; Minor Histocompatibility Antigens; Reactive Oxygen Species; Resveratrol; Tumor Cells, Cultured | 2018 |
Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin Mutations.
Topics: Acetates; Animals; beta Catenin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Child; Child, Preschool; Disease Models, Animal; Female; Glutamate-Ammonia Ligase; Glutamine; Hepatocytes; Humans; Infant; Liver Neoplasms; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutation; Phenols; Retrospective Studies; Sirolimus; TOR Serine-Threonine Kinases; Transfection; Wnt Signaling Pathway | 2019 |
Identification of the Potential Metabolic Pathways Involved in the Hepatic Tumorigenesis of Rat Diethylnitrosamine-Induced Hepatocellular Carcinoma via
Topics: Animals; Carcinogenesis; Carcinoma, Hepatocellular; Diethylnitrosamine; Glucose; Glutamic Acid; Glutamine; Glutathione; Lipids; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Metabolic Networks and Pathways; Rats; Rats, Sprague-Dawley | 2019 |
Position Is Destiny: Metabolism and Cell Identity.
Topics: beta Catenin; Carcinoma, Hepatocellular; Glutamine; Humans; Liver Neoplasms; Mechanistic Target of Rapamycin Complex 1; Mutation; Wnt Signaling Pathway | 2019 |
Mammalian Target of Rapamycin Inhibitors, New Drugs for Beta-Catenin-Mutated Hepatocellular Carcinomas?
Topics: beta Catenin; Carcinoma, Hepatocellular; Glutamine; Humans; Liver Neoplasms; Mechanistic Target of Rapamycin Complex 1; Mutation; Sirolimus | 2019 |
Oxygen flux analysis to understand the biological function of sirtuins.
Topics: Carcinoma, Hepatocellular; Fatty Acids; Glucose; Glutamine; Homeostasis; Humans; Immunoblotting; Liver Neoplasms; Mitochondria; Mitochondrial Proteins; Oxidation-Reduction; Oxygen; Oxygen Consumption; RNA, Small Interfering; Sirtuins; Tumor Cells, Cultured | 2013 |
Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts.
Topics: Animals; Antineoplastic Agents; Asparaginase; Asparagine; beta Catenin; Cadherins; Carcinoma, Hepatocellular; Enzyme Inhibitors; Glutamate-Ammonia Ligase; Glutamine; Hep G2 Cells; Humans; Ki-67 Antigen; Liver Neoplasms; Male; Methionine Sulfoximine; Mice; Mice, Nude; Mutation; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21.
Topics: Animals; Body Temperature; Carcinoma, Hepatocellular; Fibroblast Growth Factors; Gene Knockdown Techniques; Glutamine; Humans; Lipid Metabolism; Liver; Liver Neoplasms; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, 129 Strain; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Multiprotein Complexes; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; RNA, Messenger; Signal Transduction; TOR Serine-Threonine Kinases; Transcription Factors; Tuberous Sclerosis Complex 1 Protein; Tumor Suppressor Proteins | 2014 |
Retinoic acid-related orphan receptor alpha reprograms glucose metabolism in glutamine-deficient hepatoma cells.
Topics: Adenosine Triphosphate; Adult; Aged; Carcinoma, Hepatocellular; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Female; Glucose; Glutamine; Glycolysis; Humans; Liver Neoplasms; Male; Middle Aged; Nuclear Receptor Subfamily 1, Group F, Member 1; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Tumor Suppressor Protein p53 | 2015 |
PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer.
Topics: Animals; Breast Neoplasms; Carbon Isotopes; Cell Hypoxia; Cell Line, Tumor; Female; Gas Chromatography-Mass Spectrometry; Glutamine; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Metabolic Engineering; Metabolome; Mice; Mice, Inbred BALB C; Oxidative Phosphorylation; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; RNA Interference; RNA, Small Interfering | 2015 |
LRH-1-dependent programming of mitochondrial glutamine processing drives liver cancer.
Topics: Animals; Carcinogenesis; Diethylnitrosamine; Gene Expression Regulation, Neoplastic; Glutaminase; Glutamine; Liver; Liver Neoplasms; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Knockout; Mitochondria; Multiprotein Complexes; Receptors, Cytoplasmic and Nuclear; Signal Transduction; TOR Serine-Threonine Kinases | 2016 |
Yap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growth.
Topics: Adaptor Proteins, Signal Transducing; Animals; Animals, Genetically Modified; Carcinoma, Hepatocellular; Cell Proliferation; Cell Transformation, Neoplastic; Glutamine; Humans; Liver; Liver Neoplasms; Phosphoproteins; Trans-Activators; Transcription Factors; YAP-Signaling Proteins; Zebrafish; Zebrafish Proteins | 2016 |
Hepatitis C virus infection triggers a tumor-like glutamine metabolism.
Topics: Biopsy, Needle; Carcinoma, Hepatocellular; Cells, Cultured; Glutamine; Hepacivirus; Hepatitis C, Chronic; Hepatocytes; Humans; Immunohistochemistry; Liver Neoplasms; Real-Time Polymerase Chain Reaction; RNA, Small Interfering; Statistics, Nonparametric; Transfection; Virus Replication | 2017 |
MYC-driven inhibition of the glutamate-cysteine ligase promotes glutathione depletion in liver cancer.
Topics: Animals; Cell Line, Tumor; Cluster Analysis; Disease Models, Animal; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glutamate-Cysteine Ligase; Glutamine; Glutathione; Humans; Liver Neoplasms; Metabolic Networks and Pathways; Metabolome; Metabolomics; Mice; Mice, Transgenic; MicroRNAs; Oxidative Stress; Proto-Oncogene Proteins c-myc; RNA Interference | 2017 |
[Metabonomic study of blood plasma in the assessment of liver graft function].
Topics: Acetone; Alanine; Biomarkers; Blood Glucose; Carcinoma; Choline; Glutamine; Humans; Lactic Acid; Liver; Liver Neoplasms; Liver Transplantation; Magnetic Resonance Spectroscopy; Male; Metabolome; Succinic Acid; Treatment Outcome; Valine | 2007 |
13C MR spectroscopy measurements of glutaminase activity in human hepatocellular carcinoma cells using hyperpolarized 13C-labeled glutamine.
Topics: Biomarkers, Tumor; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cell Line, Tumor; Diagnosis, Computer-Assisted; Enzyme Activation; Glutaminase; Glutamine; Humans; Liver Neoplasms; Magnetic Resonance Spectroscopy; Neoplasm Proteins | 2008 |
Magnetic resonance spectroscopy on hepatocellular carcinoma after transcatheter arterial chemoembolization.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Choline; Female; Glucose; Glutamic Acid; Glutamine; Glycogen; Humans; Lipids; Liver Neoplasms; Magnetic Resonance Spectroscopy; Male; Middle Aged | 2010 |
Desamidation of glutamine and asparagine in normal and neoplastic hepatic tissues.
Topics: Amino Acids; Asparagine; Glutamine; Liver Neoplasms; Neoplasms | 1947 |
L-Asparaginase and inhibitors of glutamine synthetase disclose glutamine addiction of β-catenin-mutated human hepatocellular carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Asparaginase; Autophagy; beta Catenin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Eukaryotic Initiation Factor-2B; Gene Silencing; Glutamate-Ammonia Ligase; Glutamine; Humans; Liver Neoplasms; Molecular Targeted Therapy; Mutant Proteins; Neoplasm Proteins; Phosphorylation; Protein Processing, Post-Translational; Recombinant Proteins | 2011 |
Zonation related function and ubiquitination regulation in human hepatocellular carcinoma cells in dynamic vs. static culture conditions.
Topics: beta Catenin; Carcinoma, Hepatocellular; Cell Culture Techniques; Cell Line, Tumor; Cytochrome P-450 Enzyme System; Gene Expression Regulation, Neoplastic; Glutamine; Humans; Liver Neoplasms; Microfluidic Analytical Techniques; Protein Kinases; Proteome; Signal Transduction; Ubiquitin; Ubiquitination | 2012 |
Deregulated MYC expression induces dependence upon AMPK-related kinase 5.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Respiration; Cell Survival; Cell Transformation, Neoplastic; Disease Models, Animal; Doxycycline; Electron Transport; Gene Expression Regulation, Neoplastic; Genes, myc; Glutamine; Homeostasis; Humans; Liver Neoplasms; Mechanistic Target of Rapamycin Complex 1; Mice; Mitochondria; Multiprotein Complexes; Oncogene Protein p55(v-myc); Protein Biosynthesis; Protein Kinases; Proteins; Repressor Proteins; RNA Interference; Signal Transduction; TOR Serine-Threonine Kinases | 2012 |
Molecular and functional analysis of glutamine uptake in human hepatoma and liver-derived cells.
Topics: Amino Acid Transport System ASC; Biological Transport; Blotting, Northern; Carcinoma, Hepatocellular; Carrier Proteins; Cell Division; Cells, Cultured; Fibroblasts; Glutamate-Ammonia Ligase; Glutamine; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Minor Histocompatibility Antigens; Reference Values; Reverse Transcriptase Polymerase Chain Reaction | 2002 |
Biochemical changes during experimental carcinogenesis. II. Glutamine and glutamic acid metabolism in perfused livers of azo dye-fed rats.
Topics: Animals; Azo Compounds; Carcinogenesis; Carcinogens; Glutamates; Glutamine; Liver Neoplasms; Neoplasms; Rats | 1959 |
FREE AMINO ACIDS OF HUMAN BREAST CANCER.
Topics: Amino Acids; Asparagine; Aspartic Acid; Breast Neoplasms; Chromatography; Citrulline; Glutamates; Glutamine; Glycine; Humans; Isoleucine; Leucine; Liver Neoplasms; Lung Neoplasms; Mice; Neoplasms; Neoplasms, Experimental; Phenylalanine; Proline; Research; Serine; Threonine; Tyrosine | 1964 |
ENZYMES RELATED TO GLUTAMINE METABOLISM IN TUMOR-BEARING RATS.
Topics: Amino Acids; Blood; Carcinoma, Hepatocellular; Glutamine; Hepatectomy; Ligases; Liver; Liver Neoplasms; Rats; Research; Transferases | 1965 |
Inducible antisense RNA targeting amino acid transporter ATB0/ASCT2 elicits apoptosis in human hepatoma cells.
Topics: Amino Acid Transport System ASC; Apoptosis; Biological Transport, Active; Blotting, Northern; Blotting, Western; Carcinoma, Hepatocellular; Caspases; Cell Division; Cell Line, Tumor; DNA Fragmentation; Enzyme Activation; Genetic Vectors; Glutamine; Humans; In Situ Nick-End Labeling; Kinetics; Liver Neoplasms; Minor Histocompatibility Antigens; RNA, Antisense; Transfection | 2004 |
Glutamine availability up-regulates expression of the amino acid transporter protein ASCT2 in HepG2 cells and stimulates the ASCT2 promoter.
Topics: Amino Acid Sequence; Amino Acid Transport System ASC; Animals; Antibodies; Biological Transport, Active; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cell Proliferation; Chlorocebus aethiops; Cloning, Molecular; COS Cells; Gene Expression Regulation, Neoplastic; Glutamine; Humans; Liver Neoplasms; Mice; Minor Histocompatibility Antigens; Molecular Sequence Data; Peptides; Promoter Regions, Genetic; Rats; Up-Regulation | 2004 |
Glutamine, insulin and glucocorticoids regulate glutamine synthetase expression in C2C12 myotubes, Hep G2 hepatoma cells and 3T3 L1 adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Carcinoma, Hepatocellular; Dexamethasone; Enzyme Induction; Glucocorticoids; Glutamate-Ammonia Ligase; Glutamine; Hepatocytes; Humans; Insulin; Liver Neoplasms; Mice; Muscle Fibers, Skeletal; RNA, Messenger | 2007 |
Postchemotherapy hyperammonemic encephalopathy emulating ornithine transcarbamoylase (OTC) deficiency.
Topics: Adult; Arginine; Carcinoma, Hepatocellular; Citrulline; Female; Glutamine; Hepatic Encephalopathy; Humans; Hyperammonemia; Liver Neoplasms; Ornithine; Ornithine Carbamoyltransferase Deficiency Disease; Orotic Acid; Polymorphism, Single-Stranded Conformational; Syndrome | 2008 |
Purification of gamma-glutamyltranspeptidase (gamma-GTP) from human hepatocellular carcinoma (HCC), and comparison of gamma-GTP with the enzyme from human kidney.
Topics: Carcinoma, Hepatocellular; gamma-Glutamyltransferase; Glutamates; Glutamine; Hot Temperature; Humans; Hydrogen-Ion Concentration; Immunodiffusion; Isoelectric Point; Isoenzymes; Kidney; Kinetics; Liver Neoplasms; Molecular Weight | 1983 |
Comparison of system N in fetal hepatocytes and in related cell lines.
Topics: Aging; Amino Acids; Aminoisobutyric Acids; Animals; Asparagine; Biological Transport; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Cell Line; Ethylmaleimide; Glutamine; Histidine; Humans; Hydrogen-Ion Concentration; Lithium; Liver; Liver Neoplasms; Sodium | 1983 |
Effect of treatment with glutaurine on human antibody-dependent cell-mediated cytotoxicity (ADCC).
Topics: Adult; Aged; Animals; Antibody-Dependent Cell Cytotoxicity; Breast Neoplasms; Colonic Neoplasms; Female; Glutamine; Hodgkin Disease; Humans; Immunoglobulin Fc Fragments; Liver Neoplasms; Lymphocytes; Lymphoma; Male; Middle Aged; Multiple Myeloma; Parathyroid Hormone; Taurine; Urinary Bladder Neoplasms | 1981 |
Tracing 15N with chemical reaction interface mass spectrometry: a demonstration using 15N-labeled glutamine and asparagine substrates in cell culture.
Topics: Asparagine; Carcinoma, Hepatocellular; Culture Media; Gas Chromatography-Mass Spectrometry; Glutamine; Humans; Liver Neoplasms; Nitrogen Isotopes; Tumor Cells, Cultured | 1994 |
Clinical significance of measuring plasma concentrations of glutamine and glutamate in alcoholic liver diseases.
Topics: Acute Disease; Biomarkers; Carcinoma, Hepatocellular; Chronic Disease; Fatty Liver, Alcoholic; gamma-Glutamyltransferase; Glutamates; Glutamic Acid; Glutamine; Hepatitis; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Diseases; Liver Diseases, Alcoholic; Liver Neoplasms; Temperance | 1993 |
Modulation of cellular proliferation alters glutamine transport and metabolism in human hepatoma cells.
Topics: Amino Acid Transport Systems; Amino Acids; Animals; Biological Transport; Butyrates; Butyric Acid; Carcinoma, Hepatocellular; Carrier Proteins; Cell Division; Female; Glutaminase; Glutamine; Humans; Liver Neoplasms; Male; Novobiocin; Rats; Rats, Inbred F344; Time Factors; Tumor Cells, Cultured | 1994 |
Adaptive regulation of amino acid transport in nutrient-deprived human hepatomas.
Topics: Adaptation, Physiological; Alanine; Amino Acids; Arginine; Biological Transport; Carcinoma, Hepatocellular; Cell Division; Cell Line; Glutamine; Humans; Leucine; Liver Neoplasms; Tumor Cells, Cultured | 1996 |
HTF: A b-ZIP transcription factor that is closely related to the human XBP/TREB5 and is activated by hepatocellular carcinoma in rats.
Topics: Amino Acid Sequence; Animals; Base Sequence; Basic-Leucine Zipper Transcription Factors; Binding Sites; Carcinoma, Hepatocellular; Cloning, Molecular; DNA-Binding Proteins; DNA, Complementary; Glutamine; Humans; Leucine Zippers; Liver; Liver Neoplasms; Molecular Sequence Data; Neoplasm Proteins; Nuclear Proteins; Oligodeoxyribonucleotides; Open Reading Frames; Proline; Rats; Recombinant Proteins; Regulatory Factor X Transcription Factors; RNA, Messenger; Transcription Factors; Transcription, Genetic; X-Box Binding Protein 1 | 1996 |
Inhibitory effect of antineoplaston A10 and AS2-1 on human hepatocellular carcinoma.
Topics: Antineoplastic Agents; Benzeneacetamides; Carcinoma, Hepatocellular; Drug Combinations; Glutamine; Humans; Liver Neoplasms; Phenylacetates; Piperidones; Tumor Cells, Cultured | 1996 |
c-myc-Dependent hepatoma cell apoptosis results from oxidative stress and not a deficiency of growth factors.
Topics: Apoptosis; Carcinoma, Hepatocellular; Catalase; Cell Division; Culture Media, Serum-Free; Dimethyl Sulfoxide; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Genes, myc; Glutamine; Glutathione; Growth Substances; Humans; Hydrogen Peroxide; Liver Neoplasms; Oxidative Stress; Proto-Oncogene Proteins c-myc; Tumor Cells, Cultured; Zinc | 1997 |
Rat hepatoma cells express novel transport systems for glutamine and glutamate in addition to those present in normal rat hepatocytes.
Topics: Amino Acid Transport System X-AG; Animals; Aspartic Acid; Biological Transport; Carrier Proteins; Excitatory Amino Acid Transporter 3; Glutamate Plasma Membrane Transport Proteins; Glutamates; Glutamine; Hydrogen-Ion Concentration; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Molecular Weight; Rats; Sodium; Symporters | 1998 |
Down-regulation of negative acute-phase response genes by hypotonic stress in HepG2 hepatoma cells.
Topics: Acute-Phase Reaction; alpha-2-HS-Glycoprotein; Alpha-Globulins; Blood Proteins; Carcinoma, Hepatocellular; Gene Expression Regulation, Neoplastic; Glutamine; Glyceraldehyde-3-Phosphate Dehydrogenases; Glycoproteins; Humans; Hypotonic Solutions; Liver Neoplasms; Membrane Glycoproteins; Promoter Regions, Genetic; Protein Precursors; RNA, Messenger; Serine Proteinase Inhibitors; Trypsin Inhibitor, Kunitz Soybean; Tumor Cells, Cultured | 1998 |
Amino acid uptake and regulation in multicellular hepatoma spheroids.
Topics: Amino Acid Transport System ASC; Amino Acids; Arginine; beta-Alanine; Biological Transport; Blotting, Northern; Carcinogens; Carcinoma, Hepatocellular; Carrier Proteins; Cell Culture Techniques; Cell Division; Gene Expression; Glutamine; Humans; Leucine; Liver Neoplasms; Microscopy, Electron, Scanning; Minor Histocompatibility Antigens; Protein Kinase C; Receptors, Virus; RNA, Messenger; Sodium; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 2000 |
Effects of glutamine on tumor growth and apoptosis of hepatoma cells.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Division; Glutamine; Glutathione; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Malondialdehyde; Mice; Neoplasm Transplantation; Nitric Oxide; Tumor Cells, Cultured | 2000 |
Involvement of protein synthesis in the post-translational control of glutamine synthetase activity of cultured hepatoma cells.
Topics: Carcinoma, Hepatocellular; Cell Line; Cycloheximide; Emetine; Glutamate-Ammonia Ligase; Glutamine; Kinetics; Liver Neoplasms; Protein Biosynthesis | 1976 |
Potential inhibitors of L-asparagine biosynthesis. 2. Chemistry and biological activity of beta-hydroxyaspartic acid and its derivatives.
Topics: Animals; Asparagine; Aspartic Acid; Carcinoma, Hepatocellular; Depression, Chemical; Glutamine; Hydroxy Acids; Ligases; Liver Neoplasms; Male; Molecular Conformation; Neoplasms, Experimental; Rats; Stereoisomerism; Structure-Activity Relationship | 1975 |
Potential inhibitors of L-asparagine biosynthesis. 3. Aromatic sulfonyl fluoride analogs of L-asparagine and L-glutamine.
Topics: Animals; Asparagine; Aspartate-Ammonia Ligase; Carcinoma, Hepatocellular; Depression, Chemical; Glutamine; Liver Neoplasms; Neoplasms, Experimental; Rats; Sarcoma, Experimental; Sulfones | 1975 |
Specificity of the glutamine-binding site involved in the reguation of glutamine-synthetase activity in hepatoma tissue-culture cells.
Topics: Biological Transport, Active; Carcinoma, Hepatocellular; Cell Line; Diazooxonorleucine; Enzyme Induction; Glutamate-Ammonia Ligase; Glutamine; Kinetics; Liver Neoplasms; Methionine; Neoplasms, Experimental; Sulfones | 1975 |
Glutaminase and glutamine synthetase activities in human cirrhotic liver and hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Glutamate-Ammonia Ligase; Glutaminase; Glutamine; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Mitochondria, Liver; Oxygen Consumption | 1992 |
Promoter-specific transactivation of hepatitis B virus transcription by a glutamine- and proline-rich domain of hepatocyte nuclear factor 1.
Topics: Animals; Antigens, Surface; Antigens, Viral; Base Sequence; Binding Sites; Carcinoma, Hepatocellular; Cell Line; DNA-Binding Proteins; Genetic Vectors; Genome, Viral; Glutamine; Hepatitis B virus; Hepatocyte Nuclear Factor 1; Hepatocyte Nuclear Factor 1-alpha; Hepatocyte Nuclear Factor 1-beta; Humans; Liver Neoplasms; Molecular Sequence Data; Nuclear Proteins; Oligodeoxyribonucleotides; Plasmids; Proline; Promoter Regions, Genetic; Rats; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transfection | 1991 |
Pathway of glutamate oxidation and its regulation in the HuH13 line of human hepatoma cells.
Topics: Alanine Transaminase; Aminooxyacetic Acid; Aspartate Aminotransferases; Bicarbonates; Carcinoma, Hepatocellular; Glutamate Dehydrogenase; Glutamates; Glutamic Acid; Glutamine; Humans; Liver Neoplasms; Mitochondria; Mitochondria, Liver; Oxidation-Reduction; Oxygen Consumption; Succinates; Succinic Acid; Tumor Cells, Cultured | 1991 |
Characterization of glutamate dehydrogenase isoproteins purified from the cerebellum of normal subjects and patients with degenerative neurological disorders, and from human neoplastic cell lines.
Topics: Adolescent; Adult; Aged; Amino Acids; Carcinoma, Hepatocellular; Cell Line; Cerebellar Cortex; Cerebellum; Child; Glioma; Glutamate Dehydrogenase; Glutamine; Humans; Isoenzymes; Kinetics; Liver Neoplasms; Male; Middle Aged; Nervous System Diseases; Neurotransmitter Agents; Reference Values; Tumor Cells, Cultured | 1989 |
Perfusion of colorectal hepatic metastases. Relative distribution of flow from the hepatic artery and portal vein.
Topics: Adult; Aged; Colonic Neoplasms; Female; Glutamine; Humans; Liver Neoplasms; Male; Middle Aged; Radionuclide Imaging; Rectal Neoplasms; Regional Blood Flow; Technetium Tc 99m Aggregated Albumin; Technetium Tc 99m Sulfur Colloid | 1987 |
Regulation of glutamine synthetase activity of hepatoma tissue culture cells by glutamine and dexamethasone.
Topics: Carbon Radioisotopes; Carcinoma, Hepatocellular; Cells, Cultured; Clone Cells; Cycloheximide; Dactinomycin; Dexamethasone; Dose-Response Relationship, Drug; Enzyme Induction; Fluorides; Glutamate-Ammonia Ligase; Glutamine; Kinetics; Liver Neoplasms; Time Factors; Tyrosine Transaminase | 1973 |
The population-dependent requirement by cultured mammalian cells for metabolites which they can synthesize. II. Glutamic acid and glutamine; aspartic acid and asparagine.
Topics: Animals; Asparagine; Aspartic Acid; Carcinoma 256, Walker; Carcinoma, Hepatocellular; Culture Techniques; Glucose; Glutamates; Glutamine; Liver Neoplasms; Rats; Sarcoma, Experimental | 1966 |
Incorporation of bicarbonate-14 C into pyrimidines and into ribonucleic acid of the Novikoff ascites tumor cell.
Topics: Ammonia; Animals; Aspartic Acid; Bicarbonates; Carcinoma, Hepatocellular; Chromatography, Ion Exchange; Diazooxonorleucine; Glutamine; In Vitro Techniques; Liver Neoplasms; Neoplasms, Experimental; Orotic Acid; Pyrimidines; Rats; RNA, Neoplasm; Uracil Nucleotides | 1967 |
Asparagine biosynthesis by the Novikoff Hepatoma isolation, purification, property, and mechanism studies of the enzyme system.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Ammonium Chloride; Animals; Asparagine; Aspartic Acid; Carbon Isotopes; Carcinoma, Hepatocellular; Diphosphates; Female; Glutamine; Hydrogen-Ion Concentration; Hydroxamic Acids; Hydroxylamines; Liver Neoplasms; Magnesium; Manganese; Neoplasms, Experimental; Potassium; Rats | 1968 |
A phosphate activated glutaminase in rat liver different from that in kidney and other tissues.
Topics: Acetates; Animals; Brain; Carcinoma, Hepatocellular; Centrifugation, Density Gradient; Chloromercuribenzoates; Female; Fetus; Glutaminase; Glutamine; Hydrogen-Ion Concentration; Intestine, Small; Isoenzymes; Kidney; Kinetics; Liver; Liver Neoplasms; Liver Regeneration; Male; Mitochondria; Phosphates; Pyruvates; Rats; Vibration | 1968 |
Induction of glutamine synthetase by cortisol.
Topics: Adrenal Glands; Adrenalectomy; Ammonia; Aniline Compounds; Animals; Azo Compounds; Carcinoma 256, Walker; Carcinoma, Hepatocellular; Dactinomycin; Depression, Chemical; Dietary Proteins; Enzyme Induction; Glutamine; Hydrocortisone; Ligases; Liver; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Neoplasm Transplantation; Neoplasms, Experimental; p-Dimethylaminoazobenzene; Rats; Starvation; Stimulation, Chemical; Time Factors | 1968 |
Assays of glutamine and its aminotransferase with the enol-borate of phenylpyruvate.
Topics: Age Factors; Animals; Asparagine; Boric Acids; Carcinoma, Hepatocellular; Cold Temperature; Drug Stability; Female; Fetus; Glutamates; Glutamine; Hydrogen-Ion Concentration; Kidney; Kinetics; Liver Neoplasms; Liver Regeneration; Male; Mammary Neoplasms, Experimental; Mathematics; Methods; Neoplasms, Experimental; Organ Specificity; Phenylpyruvic Acids; Rats; Sex Factors; Solubility; Spectrophotometry; Time Factors; Transaminases; Ultraviolet Rays | 1970 |
Responsiveness of glutamine-metabolizing enzymes in Morris hepatomas to metabolic modulations.
Topics: Adrenalectomy; Animal Feed; Animals; Animals, Laboratory; Carcinoma, Hepatocellular; Cell Line; Chromosomes; Dactinomycin; Dietary Proteins; Enzyme Activation; Glutaminase; Glutamine; Hydrocortisone; Ligases; Liver Neoplasms; Neoplasm Transplantation; Neoplasms, Experimental; Rats; Thyroxine; Transaminases; Transplantation, Homologous | 1970 |
Glutamine and glutamine synthetase in fetal, adult and neoplastic rat tissues.
Topics: Animals; Carcinoma; Carcinoma 256, Walker; Carcinoma, Hepatocellular; Enzyme Repression; Female; Fetus; Glutamine; Hydrocortisone; Ligases; Liver; Liver Neoplasms; Liver Regeneration; Mammary Neoplasms, Experimental; Neoplasm Transplantation; Pregnancy; Rats | 1971 |
L-glutamine:D-fructose 6-phosphate amidotransferase in tumors and the liver of tumor-bearing animals.
Topics: Animals; Ascitic Fluid; Brain; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Chemical Precipitation; Chromatography, Gel; Colon; Dialysis; Dithiothreitol; Fructosephosphates; Glucosamine; Glucosephosphates; Glutamine; Glycosaminoglycans; Hexoses; Intestines; Kidney; Kinetics; Liver; Liver Neoplasms; Lung; Male; Mice; Muscles; Myocardium; Neoplasm Transplantation; Neoplasms, Experimental; Nucleoside Diphosphate Sugars; Rats; Sarcoma, Yoshida; Spleen; Stomach; Transaminases; Uracil Nucleotides | 1971 |
Activities of sialic acid-synthesizing enzymes in rat liver and rat and mouse tumors.
Topics: Acetates; Animals; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Cytosine Nucleotides; Fructosephosphates; Glucosamine; Glutamine; Hexosamines; Isomerases; Liver; Liver Neoplasms; Lyases; Male; Mannose; Mice; Neoplasms, Experimental; Neuraminic Acids; Nucleoside Diphosphate Sugars; Nucleotidyltransferases; Phosphoenolpyruvate; Phosphoric Acids; Phosphotransferases; Rats; Sarcoma, Yoshida; Transaminases; Uracil Nucleotides | 1971 |
Production of L-asparagine by tumor cells and the effect of asparagine analogs.
Topics: Amino Acids; Animals; Asparaginase; Asparagine; Aspartic Acid; Azo Compounds; Bromine; Carbon Isotopes; Carcinoma, Hepatocellular; Chlorine; Glutamine; Kinetics; Leukemia, Experimental; Liver Neoplasms; Lymphoma, Non-Hodgkin; Mast Cells; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Rats; Rats, Inbred Strains; Sarcoma 180 | 1972 |
Radioassay for enzymic production of glutamate from glutamine.
Topics: Animals; Carbon Isotopes; Carcinoma, Hepatocellular; Chromatography, Thin Layer; Columbidae; Culture Techniques; Glutamates; Glutamine; Hydrogen-Ion Concentration; Kinetics; Liver; Liver Neoplasms; Methods; Pentosephosphates; Pentosyltransferases; Phosphoric Acids; Rats; Ribose; Tritium | 1972 |
[Serum gamma glutamyl transpeptidase in hepatobiliary diseases. Comparison with alkaline phosphatase and aryl amidase].
Topics: Acute Disease; Alanine Transaminase; Alkaline Phosphatase; Aminopeptidases; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Chronic Disease; Glutamine; Hepatitis; Humans; Leucyl Aminopeptidase; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Pancreatitis | 1972 |
Distribution of glutamine hexosephosphate aminotransferase in rat tissues; changes with state of differentiation.
Topics: Aging; Animals; Brain; Carcinoma 256, Walker; Carcinoma, Hepatocellular; Cell Differentiation; Female; Fetus; Fructosephosphates; Glucose; Glutamine; Intestines; Kidney; Kidney Neoplasms; Kinetics; Lactation; Liver; Liver Neoplasms; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Muscles; Myocardium; Placenta; Pregnancy; Rats; Rats, Inbred Strains; Rhabdomyosarcoma; Salivary Glands; Transaminases | 1973 |
Effect of growth conditions on the activity of ornithine decarboxylase in cultured hepatoma cells. I. Effect of amino acid supply.
Topics: Amino Acids; Animals; Arginine; Asparagine; Carbon Radioisotopes; Carboxy-Lyases; Carcinoma, Hepatocellular; Cell Line; Cells, Cultured; Culture Media; Cycloheximide; Drug Synergism; Glutamine; Glycine; Immune Sera; Leucine; Liver Neoplasms; Neoplasm Proteins; Ornithine; Proline; Pyridoxal; Rats; Serine; Stimulation, Chemical; Time Factors | 1974 |
Effect of uridine on de novo pyrimidine biosynthesis in rat hepatoma cells in culture.
Topics: Amidohydrolases; Animals; Aspartate Carbamoyltransferase; Carbamates; Carbon Dioxide; Carbon Radioisotopes; Carboxy-Lyases; Carcinoma, Hepatocellular; Clone Cells; Cycloheximide; Dactinomycin; DNA, Neoplasm; Glutamine; Kinetics; Liver Neoplasms; Neoplasms, Experimental; Orotic Acid; Pentosyltransferases; Phosphotransferases; Pyrimidine Nucleotides; Rats; Ribonucleotides; RNA, Neoplasm; Uridine | 1974 |
Comparison of the properties of glucosaminephosphate isomerase (glutamine-forming) from rat liver and a hepatoma.
Topics: Animals; Antigen-Antibody Reactions; Carbohydrate Epimerases; Carcinoma, Hepatocellular; Chromatography, Ion Exchange; Dithiothreitol; Fructosephosphates; Glucosamine; Glutamine; Isoelectric Focusing; Liver; Liver Neoplasms; Male; Rabbits; Rats; Sarcoma, Yoshida; Uridine Diphosphate Sugars | 1974 |
Glutamine phosphoribosylpyrophosphate amidotransferase: increased activity in hepatomas.
Topics: Animals; Carcinoma, Hepatocellular; Glutamine; Kidney; Kidney Neoplasms; Liver; Liver Neoplasms; Liver Regeneration; Male; Neoplasms, Experimental; Pentosephosphates; Pentosyltransferases; Rats; Rats, Inbred Strains; Ribose; Ultracentrifugation | 1974 |
The role of glutamine in the oxidative metabolism of malignant cells.
Topics: Ammonia; Animals; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Cyanides; Glutamates; Glutaminase; Glutamine; Hydrazones; In Vitro Techniques; Ketoglutaric Acids; Kinetics; Liver Neoplasms; Mice; Mitochondria; NADP; Neoplasms, Experimental; Oxygen Consumption; Pyruvates; Rats; Rotenone | 1972 |
Clonal differences in glutamine synthetase activity of hepatoma cells. Effects of glutamine and dexamethasone.
Topics: Carcinoma, Hepatocellular; Cell Line; Cell Survival; Clone Cells; Culture Media; Dexamethasone; Glutamate-Ammonia Ligase; Glutamine; Liver Neoplasms; Methods; Neoplasms, Experimental; Tyrosine Transaminase | 1972 |
Utilization of L-glutamine in intercellular adhesion: ascites tumor and embryonic cells.
Topics: Animals; Azaserine; Carcinoma, Ehrlich Tumor; Cell Adhesion; Cell Aggregation; Cells, Cultured; Chick Embryo; Culture Media; Cytological Techniques; Glutamine; Indicators and Reagents; Liver Neoplasms; Mice; Norleucine; Retina; Sarcoma 180; Time Factors; Trypsin | 1973 |
The diagnosis of hepatobiliary diseases by serum enzyme analyses.
Topics: Alkaline Phosphatase; Aminohydrolases; Aminopeptidases; Biliary Tract Diseases; Clinical Enzyme Tests; Glutamine; Guanine; Hepatitis; Humans; Liver Cirrhosis; Liver Neoplasms; Ornithine Carbamoyltransferase | 1971 |